The store will not work correctly when cookies are disabled.
N-(6-Amino-3-methoxy-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-2,3-dichlorobenzenesulfonamide
ID: ALA4089151
PubChem CID: 137644457
Max Phase: Preclinical
Molecular Formula: C13H12Cl2N6O3S
Molecular Weight: 403.25
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1nn(C)c2nc(N)nc(NS(=O)(=O)c3cccc(Cl)c3Cl)c12
Standard InChI: InChI=1S/C13H12Cl2N6O3S/c1-21-11-8(12(19-21)24-2)10(17-13(16)18-11)20-25(22,23)7-5-3-4-6(14)9(7)15/h3-5H,1-2H3,(H3,16,17,18,20)
Standard InChI Key: XTBTVGBOOSJBMO-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
30.1757 -12.8793 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.5903 -12.1645 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
29.7639 -12.1628 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.3084 -12.5735 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.5917 -11.3370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3073 -10.9286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3063 -10.1029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5893 -9.6902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8720 -10.1091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8765 -10.9333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7935 -13.5585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7897 -14.8959 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.2778 -14.2291 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.0046 -14.6376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0110 -13.8150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3028 -13.4001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5880 -13.8066 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.5856 -14.6324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2943 -15.0435 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.0491 -12.7726 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.1641 -11.3519 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
29.1541 -9.6997 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
33.8575 -12.6009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0422 -15.6828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8689 -15.0437 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 2 1 0
2 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
11 15 1 0
14 12 1 0
12 13 1 0
13 11 2 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
16 4 1 0
11 20 1 0
10 21 1 0
9 22 1 0
20 23 1 0
12 24 1 0
18 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 403.25 | Molecular Weight (Monoisotopic): 402.0069 | AlogP: 2.06 | #Rotatable Bonds: 4 |
Polar Surface Area: 125.02 | Molecular Species: ACID | HBA: 8 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 5.59 | CX Basic pKa: 0.32 | CX LogP: 2.44 | CX LogD: 1.55 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.68 | Np Likeness Score: -1.93 |
References
1. Miah AH, Champigny AC, Graves RH, Hodgson ST, Percy JM, Procopiou PA.. (2017) Identification of pyrazolopyrimidine arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists., 25 (20): [PMID:28801066] [10.1016/j.bmc.2017.07.052] |